Indication
Treatment of Rett syndrome in adults and paediatric patients 2 years of age and older
Loading your page…
Loading your page…
Rett Syndrome
Marketing Authorisation Holder: Acadia Pharmaceuticals B.V.
INN: trofinetide
AI Drug & Interaction Analysis
Free account required
Ask Osler about Daybu: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.